Our previous reports of significantly different clinical outcome of L-L compared to multiple metastatic disease [3], particularly in KRAS wild-type patients, while not in KRAS mutant [5], were confirmed in young-elderly patients and should be prospectively verified. Here, KRAS is linked to metastatic neoplasm.